These drugs are taken once weekly by subcutaneous injection (injection under the skin) and are used for improving blood sugar levels, chronic weight management, and cardiovascular risk reduction, depending on the specific drug
The agency found insufficient clinical safety information and insufficient evidence to conclude effectiveness for the nominated use it assessed
However, patients with existing heart conditionsparticularly those with a history of rapid heart rate (atrial fibrillation) or certain arrhythmiasshould discuss GLP-1 therapy with their cardiologist before starting
Compared to Semaglutide, another weight-loss medication that focuses only on GLP-1 receptors, Tirzepatide consistently achieves better results in clinical trials
Critics argue aggressive direct-to-consumer advertising may encourage inappropriate prescribing and higher costs
This peptide combination enhances lean muscle mass, aids in fat loss, and promotes overall rejuvenation by stimulating growth hormone production